Lexston Life Sciences Corp. Financial Overview
Lexston Life Sciences Corp.'s market cap is currently C$1.55M. The company's EPS TTM is C$; its P/E ratio is -0.42; Lexston Life Sciences Corp. is scheduled to report earnings on October 15, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.